alexa Infectious Diseases Conferences Journals | Infectious Diseases Journal
Scientific Research and information

Make the best use of Researched information from 700+ peer reviewed, Open Access Journals operated by 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Meet Inspiring Speakers and Experts

Infectious Diseases Conferences

Share this page  Facebook  Twitter  LinkedIn  Google+  Pinterest   Blogger

Conference Series LLC in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , RetrovirusesFlu, HIV and Epidemiology

Market Analysis
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

Conference Series LLC 
Conference Series LLC, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.

Conference Series LLC are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.

Scope& Importance
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.

The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.

 
Retroviruses 2017

Retroviruses 2017 will be scheduled during July 27-28, 2017 Vancouver, Canada brings together renowned experts from the international scientific community to provide a premier inter-multi-trans-disciplinary to exchange their latest results related to retroviral research, infections, rational drug designs and novel therapies and relevant fields to present their research at this exclusive scientific program .The theme of the Retroviruses 2017 is  Novel therapy and innovations for treatment of retroviruses  The Retroviruses Conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology, Infectious and Molecular Virology Diseases. The International and national agencies working in the AIDS research are The Joint United Nations Program on HIV/AIDS (UNAIDS), Australian AID (AusAID), British AID (DFID), US Government Assistance (USG), German AID (GTZ), Canadian Aboriginal AIDS Network (CAAN) International Labour Organization (ILO). More than 1.2 million people in the US are living with HIV, and 1 in 8 of them don’t know it.Over the last decade, the annual number of new HIV diagnoses declined 19%.Gay and bisexual men, particularly young African American gay and bisexual men, are most affected. African Americans continue to experience the greatest burden of HIV compared to other races and ethnicities. From 2005 to 2014: Diagnoses among all women declined 40%, and among African American women, diagnoses declined 42%. Among all heterosexuals, diagnoses declined 35%, and among people who inject drugs, diagnoses declined 63%. 

Related Conferences:
35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, United States; Australasian Society for Infectious Diseases Annual Scientific Meeting, March 29 - April 1, 2017 Leura, Australia; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; Annual Congress on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 Chicago, Illinois, USA; 2nd International conference on Flu, October 31- November 02, 2016 San Francisco, California, USA; International congress on Infectious Diseases, May11-12, 2017 Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada.

Influenza 2017

Influenza 2017 is sensing the raising importance of influenza and zoonotic disease prevention, control, treatment and cure, Conference Series Ltd will host during August 21-22, 2017 Birmingham, UK. The theme of Influenza 2017 is "Lower the Impact of Influenza on Public Health" Influenza 2017 offers a unique window and opportunities to present and evidence the latest updates with a holistic approach to different areas of interest. Our intention is, to create platforms which will gather eminent scientists, medical professionals who will undoubtedly enrich the conference. Global Influenza Market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. Similarly it has also been observed that 13 major zoonotic diseases which majorly include tuberculosis and bird flu are responsible for 2.2 million deaths globally every year. The global veterinary vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021. 

Related Conferences: 3rd  International Conference on Flu and Emerging Infectious Disease, Oct 30- Nov 1, 2017, Las Vegas, USA; 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30- Nov 1, 2017, San Antonio USA; 4th Euro-Global Conferences on Infectious Diseases, during September 07-09, 2017, Paris, France; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International congress on Infectious Diseases, May11-12, 2017 Barcelona, Spain; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada; 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain.

Infectious Diseases

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. The conference attains significance when we look at the worldwide deaths due to Infectious Diseases like Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Related Conferences
5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Euro Infectious Diseases

Euro Infectious Diseases Conferences Sensing the raising importance of Infectious Diseases prevention, control, treatment and cure, Conference Series Ltd will host Euro Infectious Diseases Conference  scheduled from September 07-09, 2017 Paris, France, with a theme Preventing Emerging Infectious Diseases: New Strategy for the 21st Century.  World-renowned speakers, the most recent techniques, developments, and the newest updates in infectious diseases are hallmarks of this conference.  The conference provides an exceptional platform for the professionals who look beyond the clinical prospects. The Infectious Diseases market is poised to reach $18,156.2 million by 2019 from $12,422.8 million in 2014, at a CAGR of 7.9% from 2014 to 2019. Factors such as high prevalence rate of infectious diseases, increased demand for rapid diagnostic techniques due to slow turnaround time of current techniques, and the increase in government funding are driving market growth.
 
Related Conferences: 
4th International Congress on Infectious Diseasesduring May 11-12, 2017 in BarcelonaSpain. 5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs during June 19-20, 2017 in London, UK. 5th World Congress on Infectious Diseasesduring August 21-23, 2017 in San Francisco, California, USA.6th Euro-Global Conference on Infectious Diseases during September 07-09, 2017, at  Paris, France. 4th World Congress on Infection Prevention and Control during November 28-29, 2016 in Valencia, Spain.

Rare Diseases and Orphan Drugs

With the overwhelming success of the previous conference, “2nd Annual Congress on Rare Diseases and Orphan Drugs” is going to be held during October 30-November 1, 2017 in San Antonio, USA based upon theme “Platform to share new treatments and research for Rare Diseases”. Rare diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. The organizing committee is gearing up for an exciting and informative conference program including prompt keynote presentations, Oral talks, Poster presentations and Exhibitions which provides a  platform to discuss and learn about Rare Diseases, rare cancer, malignant glioma, Turner syndrome, Multiple myeloma, Renal cell carcinoma, Hepatocellular carcinoma, Morgellons , Diabetes in the young, Systemic Amyloidosis, Autoimmune diseases, Disorders of genetic origin, idiopathic disorders, rare genetic diseases, Orphan Drugs, Alzheimer’s Disease and many more. Right now drugs for rare diseases are the sweet spot of the biotechnology industry. Treatments for illnesses that affect only hundreds of patients can cost $200,000 or more and have built Genzyme into one of biotech’s biggest companies and Alexion and Biomarin into two of its hottest names for investors.

Related Conferences:
International Congress on Infectious Diseases May 11-12, 2017, Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017, Chicago, USA; 3rd World Congress on Rare Diseases June 29-30, 2017, London, UK; 3rd International Conference on Retroviruses and Novel Drugs July 27-28, 2016, Vancouver, Canada; 4th Euro-Global Conference on Infectious Diseases September 7-9, 2017, Paris, France

Flu 2017

Flu 2017 will be scheduled during Oct 30-Nov 02, 2017, Las Vegas, USA. We have done our outmost to get rid of the traditional approach in the elaboration of the program and most importantly, during the active sessions, in order to foster innovation and scientific curiosity. The theme for Flu 2017 is “Understanding the Flu; Risk Analysis and Prevention”. The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years.

Related Conferences:
2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30- Nov 1, 2017, San Antonio USA; 4th Euro-Global Conferences on Infectious Diseases, during September 07-09, 2017, Paris, France; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria.

Infection prevention and control

Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CDI, SSI, CRE, MRSA, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences. The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Related Conferences
3rd World Congress on Infectious Diseases, Aug 21-23, 2017 USA, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

 

Major Companies Related to Infectious Diseases

adwords